Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo, and AI/ML methods to utilize messy biological data, biopharma is prioritizing preclinical models.
The Translatable Models in Neuroscience Summit is bringing together 50+ in vitro, in vivo, and in silico model developers transforming CNS disease recapitulation and bridging the translational gap.
This an unrivalled opportunity to unite with neuroscientists, bioengineers, and AI/ML engineers to engage in meaningful discussion and advance CNS disease recapitulation, and catapult your pipeline toward the clinic.
The Translatable Models in Neuroscience Summit is bringing together 50+ in vitro, in vivo, and in silico model developers transforming CNS disease recapitulation and bridging the translational gap.
This an unrivalled opportunity to unite with neuroscientists, bioengineers, and AI/ML engineers to engage in meaningful discussion and advance CNS disease recapitulation, and catapult your pipeline toward the clinic.
